home / stock / mack / mack news


MACK News and Press, Merrimack Pharmaceuticals Inc.

Stock Information

Company Name: Merrimack Pharmaceuticals Inc.
Stock Symbol: MACK
Market: NASDAQ
Website: merrimack.com

Menu

MACK MACK Quote MACK Short MACK News MACK Articles MACK Message Board
Get MACK Alerts

News, Short Squeeze, Breakout and More Instantly...

MACK - Earnings week ahead: NVIDIA, Target, Zoom Video, Snowflake and more

2024-05-19 08:02:00 ET Retailers will also be in the spotlight, with updates anticipated from Target ( NYSE: TGT ), Lowe's ( LOW ), Macy’s ( M ), Ross Stores ( ROST ), TJX Companies ( TJX ), Ralph Lauren ( RL ) and Urban Outfitters ( URBN ).... R...

MACK - MACK Stock Earnings: Merrimack Pharmaceuticals Reported Results for Q1 2024

2024-05-16 08:53:01 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Merrimack Pharmaceuticals (NASDAQ: MACK ) just reported results for the first quarter of 2024. Merrimack Pharmaceuticals reported earnings per share of -3 cents. The c...

MACK - (MACK) On The My Stocks Page

2024-05-12 12:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MACK - Merrimack Pharmaceuticals stockholders approve plan of dissolution

2024-05-10 16:55:30 ET More on Merrimack Pharmaceuticals Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq Merrimack receives $225M milestone payment from Ipsen Financial information for Merrimack Pharmaceuticals Read...

MACK - Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a liquidat...

MACK - Merrimack Pharmaceuticals intends to declare $15.10 dividend

2024-05-09 13:36:06 ET More on Merrimack Pharmaceuticals Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq Merrimack receives $225M milestone payment from Ipsen Financial information for Merrimack Pharmaceuticals Read...

MACK - Merrimack Pharmaceuticals, Inc. Announces Anticipated Final Cash Dividend Amount of Initial Liquidating Distribution, Subject to Receipt of Stockholder Approval of Plan of Dissolution

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that the Board of Directors intends to declare a liquidating cash dividend in the amount of $15.10 per share, if stockholder approval of the Plan of Dissolution is obtained at...

MACK - (MACK) Investment Analysis

2024-05-02 18:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MACK - Expected US Company Earnings on Thursday, May 2nd, 2024

Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...

MACK - Merrimack Pharmaceuticals announces notification of plan to delist common stock on Nasdaq

2024-04-30 17:44:17 ET More on Merrimack Pharmaceuticals Merrimack receives $225M milestone payment from Ipsen Merrimack spikes as Ipsen wins FDA label expansion for cancer therapy Financial information for Merrimack Pharmaceuticals Read the full article on...

Next 10